Introduction: Brain atrophy is a widely accepted marker of disease severity with association to clinical disability in multiple sclerosis (MS). It is unclear to which extent this association reflects common age effects on both atrophy and function.Objective: To explore how functional performance in gait, upper extremities and cognition is associated with brain atrophy in patients with Clinically Isolated Syndrome (CIS) and relapsing-remitting MS (RRMS), controlling for effects of age and sex.Methods: In 27 patients with CIS, 59 with RRMS (EDSS ≤3) and 63 healthy controls (HC), 3T MRI were analyzed for T2 lesion count (T2C), volume (T2V) and brain volumes [normalized brain volume (NBV), gray matter volume (NGMV), white matter volume (NWMV), ...
BACKGROUND: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Objectives To identify Magnetic Resonance Imaging (MRI), clinical and demographic biomarkers predict...
Introduction: Brain atrophy is a widely accepted marker of disease severity with association to clin...
Introduction: Brain atrophy is a widely accepted marker of disease severity with association to clin...
INTRODUCTION: Brain atrophy is a widely accepted marker of disease severity with association to clin...
IntroductionBoth aging and multiple sclerosis (MS) cause central nervous system (CNS) atrophy. Exces...
IntroductionBoth aging and multiple sclerosis (MS) cause central nervous system (CNS) atrophy. Exces...
IntroductionBoth aging and multiple sclerosis (MS) cause central nervous system (CNS) atrophy. Exces...
Motor and cognitive disabilities are related to brain atrophy in multiple sclerosis (MS). ‘Timed up ...
Contains fulltext : 80250.pdf (publisher's version ) (Closed access)BACKGROUND: Se...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
Introduction: Cognitive motor interference (CMI) is performance impairment due to simultaneuous task...
OBJECTIVE: To evaluate cognitive changes in a cohort of radiologically isolated syndromes (RIS) sug...
INTRODUCTION: Multiple sclerosis (MS) is characterized, besides focal lesions, by brain atrophy. Th...
BACKGROUND: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Objectives To identify Magnetic Resonance Imaging (MRI), clinical and demographic biomarkers predict...
Introduction: Brain atrophy is a widely accepted marker of disease severity with association to clin...
Introduction: Brain atrophy is a widely accepted marker of disease severity with association to clin...
INTRODUCTION: Brain atrophy is a widely accepted marker of disease severity with association to clin...
IntroductionBoth aging and multiple sclerosis (MS) cause central nervous system (CNS) atrophy. Exces...
IntroductionBoth aging and multiple sclerosis (MS) cause central nervous system (CNS) atrophy. Exces...
IntroductionBoth aging and multiple sclerosis (MS) cause central nervous system (CNS) atrophy. Exces...
Motor and cognitive disabilities are related to brain atrophy in multiple sclerosis (MS). ‘Timed up ...
Contains fulltext : 80250.pdf (publisher's version ) (Closed access)BACKGROUND: Se...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
Introduction: Cognitive motor interference (CMI) is performance impairment due to simultaneuous task...
OBJECTIVE: To evaluate cognitive changes in a cohort of radiologically isolated syndromes (RIS) sug...
INTRODUCTION: Multiple sclerosis (MS) is characterized, besides focal lesions, by brain atrophy. Th...
BACKGROUND: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Objectives To identify Magnetic Resonance Imaging (MRI), clinical and demographic biomarkers predict...